Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Clinical Oncology

• Publication date

  2000-05-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2000.18.10.2143PMID 10811680
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mood and cognitive disorders in cancer patients receiving cytokine therapy.

  1999cited by this paper
• Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state.

  1999cited by this paper
• Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice

  1999cited by this paper
• Anhedonic and anxiogenic effects of cytokine exposure.

  1999cited by this paper
• Present achievements in the medical treatment of metastatic renal cell carcinoma.

  1999cited by this paper
• Differential effects of interleukin (IL)-1beta, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation.

  1998cited by this paper
• Cytokines and Sickness Behavior

  1998cited by this paper
• Effects of interferon-α, interferon-γ and cAMP on the transcriptional regulation of the serotonin transporter

  1998cited by this paper
• Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie.

  1998cited by this paper
• Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

  1998cited by this paper
• Mood and cognitive side effects of interferon-α therapy

  1998cited by this paper
• Mood and cognitive side effects of interferon-alpha therapy.

  1998cited by this paper
• Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter.

  1998cited by this paper
• Interferon-alpha and transforming growth factor-beta 1 regulate corticotropin-releasing factor release from the amygdala: comparison with the hypothalamic response.

  1997cited by this paper
• The psychological and psychiatric effects of rIL‐2 therapy: a controlled clinical trial

  1997cited by this paper
• Repeated interferon-alpha administration inhibits dopaminergic neural activity in the mouse brain.

  1997cited by this paper
• INTERFERON-α AND TRANSFORMING GROWTH FACTOR-β1 REGULATE CORTICOTROPIN-RELEASING FACTOR RELEASE FROM THE AMYGDALA: COMPARISON WITH THE HYPOTHALAMIC RESPONSE*

  1997cited by this paper
• Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life.

  1997cited by this paper
• Repeated interferon-α administration inhibits dopaminergic neural activity in the mouse brain

  1997cited by this paper
• Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation.

  1996cited by this paper
• Activation of the HPA axis by immune insults: roles and interactions of cytokines, eicosanoids, glucocorticoids.

  1996cited by this paper
• Endotoxin produces a depressive-like episode in rats.

  1996cited by this paper
• Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

  1996cited by this paper
• The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessments.

  1996cited by this paper
• Diagnostic dilemmas presented by patients with anxiety and depression.

  1995cited by this paper
• Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia

  1995cited by this paper
• Cytokines and the nervous system. I: Expression and recognition.

  1995cited by this paper
• Cytokines and the nervous system II: Actions and mechanisms of action.

  1995cited by this paper
• Neuropsychiatric symptoms during treatment with interleukin-2 and interferon-alpha.

  1993cited by this paper
• Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2

  1993cited by this paper
• Repeated injections of interferon-alpha A/D in Balb/c mice: behavioral effects.

  1993cited by this paper
• Neuropsychiatric symptoms during treatment with interleukin-2 and interferon-α

  1993cited by this paper
• Repeated Injections of Interferon-α A/D in Balb/c Mice: Behavioral Effects

  1993cited by this paper
• Residual acute confusional and hallucinatory syndromes induced by interleukin‐2/α‐interferon treatment

  1992cited by this paper
• Prostaglandins do not mediate interferon-alpha effects on mouse behavior.

  1992cited by this paper
• Prostaglandins do not mediate interferon-α effects on mouse behavior

  1992cited by this paper
• Phase II study of subcutaneous interleukin-2 in unselected patients with advanced renal cell cancer on an outpatient basis.

  1992cited by this paper
• Effets secondaires de l'interleukine 2.

  1991cited by this paper
• [Adverse effects of interleukin 2].

  1991cited by this paper
• Fever: Role of Pyrogens and Cryogens

  1991cited by this paper
• Immunoregulators in the nervous system.

  1991cited by this paper
• Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone.

  1990cited by this paper
• Psychiatric complications of long-term interferon alfa therapy.

  1987cited by this paper
• Esophagitis and gastroduodenal disorders associated with diabetic gastroparesis.

  1987cited by this paper
• A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

  1987cited by this paper
• The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

  1987cited by this paper
• Etude de l'échelle de ralentissement sur un échantillon de sujets non ralentis non déprimés

  1986cited by this paper
• Immune-neuroendocrine interactions.

  1985cited by this paper
• A New Depression Scale Designed to be Sensitive to Change

  1979cited by this paper
• Symptomatic volunteers in multicenter drug trials.

  1979cited by this paper

• Effect of an integrated mHealth supportive care program on symptom burden and self-efficacy in post-treatment breast cancer survivors: a randomized controlled trial.

  2026cites this paper
• High-dose subacute and acute Thymoquinone treatments alleviate LPS-induced depressive-like behavior in mice by reducing inflammation via the IDO/KYN pathway.

  2025cites this paper
• Flavins and Flavoproteins in the Neuroimmune Landscape of Stress Sensitization and Major Depressive Disorder

  2025cites this paper
• Towards a consensus roadmap for a new diagnostic framework for mental disorders.

  2024cites this paper
• Depression, anxiety and associated factors among cancer patients in Africa; a systematic review and meta-analysis study

  2024cites this paper
• Association between peripheral plasma cytokine levels and suicidal ideation in first-episode, drug-naïve major depressive disorder.

  2024cites this paper
• Efficacy of inflammation-based stratification for add-on celecoxib or minocycline in major depressive disorder: Protocol of the INSTA-MD double-blind placebo-controlled randomised clinical trial

  2024cites this paper
• Periodontal Pathogens and Their Links to Neuroinflammation and Neurodegeneration

  2023cites this paper
• Emotional, inflammatory, and genetic factors of resilience and vulnerability to depression in patients with premenopausal breast cancer: A longitudinal study protocol

  2023cites this paper
• ASSESSMENT OF LEVEL OF ANXIETY AND DEPRESSION AMONG PEOPLE LIVING WITH CANCER IN SELECTED CANCER HOSPITAL KOLKATA, WEST BENGAL

  2023cites this paper
• Relationships among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated with Chemotherapy for Gynecologic Cancer: A Controlled Comparison

  2023cites this paper
• Sickness Behaviour and Depression: An Updated Model of Peripheral-Central Immunity Interactions.

  2023cites this paper
• Ketamine as a therapeutic agent for depression and pain: mechanisms and evidence.

  2022cites this paper
• Predisposing role of childhood mental trauma in immunoinflammatory rheumatic diseases and mental disorders

  2022cites this paper
• Evaluation of the effect of alpha-tocopherol on anxiety and the neuroinflammatory process during alcohol withdrawal in a model of forced and chronic self-administration of liquid diet containing ethanol: behavioral and neurochemical evidence.

  2022cites this paper
• Examining the interrelationships between mindfulness‐based interventions, depression, inflammation, and cancer survival

  2022cites this paper
• Glycoprotein Acetyls and Depression: testing for directionality and potential causality using longitudinal data and Mendelian randomization analyses

  2022cites this paper
• Night shift hormone: How does melatonin affect depression?

  2022cites this paper
• The Evidence for a Causal Link Between Disease and Damaging Behavior in Pigs

  2022cites this paper
• Antidepressant Effects of NSAIDs in Rodent Models of Depression—A Systematic Review

  2022cites this paper
• The Relationship Between Fears of Cancer Recurrence and Patient Gender: A Systematic Review and Meta-Analysis

  2021cites this paper
• Enriched environment mitigates depressive behavior by changing the inflammatory activation phenotype of microglia in the hippocampus of depression model rats.

  2021cites this paper
• Cerebral Structural Abnormalities and Their Associations With Peripheral Cytokine Levels in a Group of Untreated Patients With Nasopharyngeal Carcinoma

  2021cites this paper
• The use of social network analysis to describe the effect of immune activation on group dynamics in pigs.

  2021cites this paper
• Immunological Effects of an Add-On Physical Exercise Therapy in Depressed Adolescents and Its Interplay with Depression Severity

  2021cites this paper
• Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications

  2021cites this paper
• Associations between Melatonin, Neuroinflammation, and Brain Alterations in Depression

  2021cites this paper
• Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: Preliminary findings

  2020cites this paper
• Cancer Immunotherapy Confers a Global Benefit

  2020cites this paper
• Can suicide behavior and seasonality of suicide be predicted from inflammatory parameters in adolescents?

  2020cites this paper
• Сучасні уявлення про синдром хронічного тазового болю

  2020cites this paper
• Association of pro-inflammatory cytokines with clinical features in euthymic patients with Bipolar-I-Disorder.

  2020cites this paper
• Medications associated with development of drug-induced depression

  2020cites this paper
• Using Precision Medicine with a Neurodevelopmental Perspective to Study Inflammation and Depression

  2020cites this paper
• CD300f immunoreceptor is associated with major depressive disorder and decreased microglial metabolic fitness

  2020cites this paper
• A Proposed Role for Pro-Inflammatory Cytokines in Damaging Behavior in Pigs

  2020cites this paper
• Microbiome-gut-brain axis in cancer treatment-related psychoneurological toxicities and symptoms: a systematic review

  2020cites this paper
• Immune dysregulation in depression: Evidence from genome-wide association

  2020cites this paper
• Peripheral Biomarkers of Inflammation in Depression: Evidence from Animal Models and Clinical Studies.

  2019cites this paper
• Current Concepts of Chronic Pelvic Pain Syndrome

  2019cites this paper
• Individual differences in inflammatory and oxidative mechanisms of stress-related mood disorders.

  2019cites this paper
• Inflammation- and angiogenesis-related biomarkers are correlated with cancer-related fatigue in colorectal cancer patients: Results from the ColoCare Study.

  2019cites this paper
• How to deal: Exploring the impact of coping, perceived control, and stress on immune function in patients with advanced cancer

  2019cites this paper
• Современные представления о синдроме хронической тазовой боли

  2019cites this paper
• The characteristics and risk factors for common psychiatric disorders in patients with cancer seeking help for mental health

  2019cites this paper
• Sick and grumpy: Changes in social behaviour after a controlled immune stimulation in group-housed gilts.

  2019cites this paper
• Inflammation- and angiogenesis-related biomarkers are correlated with cancer-related fatigue in colorectal cancer patients: Results from the ColoCare Cohort

  2019cites this paper
• NK Cell-Encapsulated Porous Microspheres via Microfluidic Electrospray for Tumor Immunotherapy.

  2019cites this paper
• Cognitive Behavioral Therapy for Insomnia Reduces Depression in Cancer Survivors

  2019cites this paper
• Stress-Related Disease: A Review

  2019cites this paper
• An inflammatory profile linked to increased suicide risk.

  2019cites this paper
• Overlapping Chronic Pain and Depression: Pathophysiology and Management

  2018cites this paper
• Distinct inflammatory response patterns are evident among men and women with higher depressive symptoms.

  2018cites this paper
• Pathophysiology and treatment strategies for different types of depression

  2018cites this paper
• Inflammatory Profiles in Depressed Adolescents Treated with Fluoxetine: An 8-Week Follow-up Open Study

  2018cites this paper
• Evaluation and predictive factors analyses for patient-self-reported depression, anxiety and quality of life in patients with metastatic renal cell carcinoma underwent interferon-α treatment: a prospective cohort study

  2018cites this paper
• Probiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism?

  2018cites this paper
• Gut microbiota‐immune‐brain interactions in chemotherapy‐associated behavioral comorbidities

  2018cites this paper
• The effect of lipopolysaccharide (LPS) on inflammatory markers in blood and brain and on behavior in individually-housed pigs.

  2018cites this paper
• Evolutionary Perspectives on Genetic and Environmental Risk Factors for Psychiatric Disorders.

  2018cites this paper
• ect of lipopolysaccharide ( LPS ) on in fl ammatory markers in blood and brain and on behavior in individually-housed pigs

  2018cites this paper
• Association between serotonin transporter polymorphisms (5-HTTLPR) and the MADRS Dysphoria, Retardation, and Vegetative Subscale scores in the treatment of depression

  2017cites this paper
• Gut–brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease

  2017cites this paper
• association between serotonin transporter polymorphisms (5-hTTlPr) and the MaDrs Dysphoria, retardation, and Vegetative subscale scores in the treatment of depression

  2017cites this paper
• Systems Chronotherapeutics

  2017cites this paper
• Systematic review of psychosocial outcomes for patients with advanced melanoma

  2017cites this paper
• The link between inflammation, bugs, the intestine and the brain in alcohol dependence

  2017cites this paper
• To be blamed or pitied? The effect of illness on social behavior, cytokine levels and feed intake in undocked boars.

  2017influential citation
• The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain

  2017cites this paper
• A role for the peripheral immune system in the development of alcohol use disorders?

  2017cites this paper
• Cancer Immunotherapy: Friend or Foe of Mental Health?

  2017cites this paper
• Psychiatric Disorders and Inflammation

  2017cites this paper
• Intracerebroventricular Administration of Streptozotocin as an Experimental Approach to Depression: Evidence for the Involvement of Proinflammatory Cytokines and Indoleamine-2,3-Dioxygenase

  2017cites this paper
• The Role of Brain Structure and Function in the Association Between Inflammation and Depressive Symptoms: A Systematic Review

  2016cites this paper
• Alcohol-Dependence and the Microbiota-Gut-Brain Axis

  2016cites this paper
• Role of Interferon-Gamma and Leucine-Rich Repeat Kinase 2 in Stress-Related Pathology

  2016cites this paper
• Metabolic-Inflammation Aspects of Depression and Cardiovascular Disease

  2016influential citation
• Targeted therapy and elderly people: A review.

  2016cites this paper
• Early-Life Adversity and Physical and Emotional Health Across the Lifespan: A Neuroimmune Network Hypothesis.

  2016cites this paper
• Immunoadolescence: Neuroimmune development and adolescent behavior.

  2016cites this paper
• Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression

  2016cites this paper
• Stress-Related Immune Markers in Depression: Implications for Treatment

  2016cites this paper
• Role of Inflammation in Suicide: From Mechanisms to Treatment

  2016cites this paper
• Tumor infiltrating immune cells in gliomas and meningiomas.

  2016cites this paper
• Depression as a risk factor for Alzheimer's disease: Genes, steroids, cytokines and neurogenesis - What do we need to know?

  2016cites this paper
• Différentes approches dans le traitement de la dépression post-infarctus du myocarde : effet de la desvenlafaxine et des probiotiques

  2015cites this paper
• Different Mechanisms Between Melancholic and Atypical Depression

  2015cites this paper
• Behavioural and neurobiological consequences of macrophage migration inhibitory factor gene deletion in mice

  2015cites this paper
• Measuring sickness behavior in the context of pancreatic cancer.

  2015cites this paper
• A Randomized, Double-blind, Placebo-controlled Trial of Celecoxib Augmentation of Sertraline in Treatment of Drug-naive Depressed Women: A Pilot Study

  2015cites this paper
• Enhanced inflammatory and T-helper-1 type responses but suppressed lymphocyte proliferation in patients with seasonal affective disorder and treated by light therapy.

  2015cites this paper
• CORRELATES OF DEPRESSION AND ANXIETY AMONG THE CANCER PATIENTS IN THE RADIOTHERAPY CLINIC IN UCH, IBADAN, NIGERIA

  2015cites this paper
• linical trials of N-acetylcysteine in psychiatry and neurology : systematic

  2015cites this paper
• Somatoform Disorders and Related Syndromes

  2015cites this paper
• Adolescent-Onset Depression: Are Obesity and Inflammation Developmental Mechanisms or Outcomes?

  2015cites this paper
• Symptoms: Fatigue and Cognitive Dysfunction.

  2015cites this paper
• Rodent Models of Stress-Induced Depression: The Link Between Stress and Immune System Related Changes

  2015cites this paper
• Peripheral Administration of Tumor Necrosis Factor-Alpha Induces Neuroinflammation and Sickness but Not Depressive-Like Behavior in Mice

  2015cites this paper
• Effects of Roncoleukin on Measures of Immunity and the Anxious-Depressive State Induced by Chronic Social Stress in Male Mice

  2015cites this paper
• Immunology and Developmental Psychopathology

  2015cites this paper